-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX BIOSCIENCES INC - OZEKIBART MEETS PRIMARY ENDPOINT IN CHONDROSARCOMA

Reuters·10/23/2025 20:05:53

Please log in to view news